76 related articles for article (PubMed ID: 1535772)
1. Relationships for recombinant interleukin-2-stimulated mixed lymphocyte tumor extract reaction between peripheral blood lymphocytes and regional node lymphocytes in gastric cancer patients.
Tseng CC; Nio Y; Tsubono M; Fukumoto M; Tobe T
Anticancer Res; 1992; 12(3):927-32. PubMed ID: 1535772
[TBL] [Abstract][Full Text] [Related]
2. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
3. Induction of lymphokine-activated killer activities in peripheral blood lymphocytes and regional lymph node lymphocytes against PC-9 cultured adenocarcinoma and autologous pulmonary adenocarcinoma cells.
Morikawa Y; Watanabe S; Kodama T
Jpn J Clin Oncol; 1987 Jun; 17(2):129-39. PubMed ID: 3497285
[TBL] [Abstract][Full Text] [Related]
4. [Breast cancer-specific immunity evaluated by a new in vitro method--IL-2 enhanced MLTR].
Kan N; Okino T; Kodama H; Ohgaki K; Tobe T; Inamoto T
Nihon Geka Gakkai Zasshi; 1987 Nov; 88(11):1624-31. PubMed ID: 2963207
[TBL] [Abstract][Full Text] [Related]
5. Study of tumor-associated blastogenic reactivity of peripheral blood lymphocytes and regional lymph node lymphocytes in human malignancy.
Kurosu Y; Saegusa Y; Tominaga M; Morita K
Jpn J Clin Oncol; 1983 Mar; 13(1):25-30. PubMed ID: 6834651
[TBL] [Abstract][Full Text] [Related]
6. Intranodal antitumor immunocyte infiltration in node-negative gastric cancers.
Ishigami S; Natsugoe S; Hokita S; Xiangming C; Aridome K; Iwashige H; Tokuda K; Nakajo A; Miyazono F; Aikou T
Clin Cancer Res; 2000 Jul; 6(7):2611-7. PubMed ID: 10914701
[TBL] [Abstract][Full Text] [Related]
7. Increased number of suppressor T-cells and impaired IL-2 mediated T-cell function in peripheral blood of gastric cancer patients.
Tsubono M; Nio Y; Shiraishi T; Morimoto H; Tseng CC; Kawabata K; Masai Y; Fukumoto M; Tobe T
J Clin Lab Immunol; 1990 Nov; 33(3):107-15. PubMed ID: 1966999
[TBL] [Abstract][Full Text] [Related]
8. CD3 zeta expression of regional lymph node and peripheral blood lymphocytes in gastric cancer.
Ishigami S; Natsugoe S; Miyazono F; Tokuda K; Nakajo A; Matsumoto M; Okumura H; Nakashima S; Hokita S; Maruyama I; Aikou T
Anticancer Res; 2004; 24(3b):2123-6. PubMed ID: 15274412
[TBL] [Abstract][Full Text] [Related]
9. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
[TBL] [Abstract][Full Text] [Related]
10. The clinical status and histopathological factors affecting natural killer cells of peripheral blood lymphocytes in patients with gastric cancer.
Nio Y; Shiraishi T; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T
J Clin Lab Immunol; 1991 Jul; 35(3):97-108. PubMed ID: 1668768
[TBL] [Abstract][Full Text] [Related]
11. [Adoptive immunotherapy against peritoneal metastases from stomach cancer--application of regional lymph node lymphocytes].
Okino T; Kan N; Mise K; Nakanishi M; Satoh K; Yamasaki S; Teramura Y; Inoue K; Ohgaki K; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):613-20. PubMed ID: 2351854
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
Morton BA; Ramey WG; Paderon H; Miller RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
[TBL] [Abstract][Full Text] [Related]
13. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
14. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
15. [Studies on adoptive immunotherapy using recombinant interleukin 2].
Sugiyama Y; Takao H; Saji S; Sakata K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1307-13. PubMed ID: 3488028
[TBL] [Abstract][Full Text] [Related]
16. Non-T cell disturbance causes the suppression of the autologous mixed lymphocyte reaction in patients with gastric carcinoma.
Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Noguchi K; Mizobata S; Tamai M; Hotta T; Arii K
Anticancer Res; 1995; 15(3):799-804. PubMed ID: 7645961
[TBL] [Abstract][Full Text] [Related]
17. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the cell-mediated immunity in regional lymph nodes from patients with gastric cancer].
Koba F
Fukuoka Igaku Zasshi; 1985 Apr; 76(4):104-16. PubMed ID: 3875541
[No Abstract] [Full Text] [Related]
20. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
